We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$31.8B
AUM Growth
-$1.45B
(-4.4%)
Cap. Flow
-$2.38B
Cap. Flow
% of AUM
-7.5%
Top 10 Holdings %
Top 10 Hldgs %
10.41%
Holding
1,024
New
157
Increased
273
Reduced
350
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$148M |
| 2 |
MSC Industrial Direct
MSM
|
+$96M |
| 3 |
Qualcomm
QCOM
|
+$84.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$83.6M |
| 5 |
Occidental Petroleum
OXY
|
+$60.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$154M |
| 2 |
American International
AIG
|
+$149M |
| 3 |
Intel
INTC
|
+$145M |
| 4 |
AT&T
T
|
+$124M |
| 5 |
Eli Lilly
LLY
|
+$99.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 13.58% |
| 2 | Financials | 13.37% |
| 3 | Technology | 12.81% |
| 4 | Healthcare | 10.99% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHDX
701
DELISTED
Genomic Health, Inc.
GHDX
| $3.72M | 0.01% |
150,060
+18,596
| +14% | +$510K |
|
702
Morgan Stanley
MS
$333B
| $3.71M | 0.01% |
148,320
+16,830
| +13% | +$429K |
|
703
Weyerhaeuser
WY
$17.7B
| $3.7M | 0.01% |
119,500
-27,900
| -19% | -$745K |
|
704
Vera Bradley
VRA
$104M
| $3.68M | 0.01% |
+181,026
| New | +$2.96M |
|
|
LDL
705
DELISTED
Lydall, Inc.
LDL
| $3.66M | 0.01% |
112,500
| – | – |
|
|
ANDV
706
DELISTED
Andeavor
ANDV
| $3.65M | 0.01% |
42,400
-6,000
| -12% | -$515K |
|
707
Coherus Oncology
CHRS
$222M
| $3.59M | 0.01% |
169,209
-13,320
| -7% | -$218K |
|
|
APIC
708
DELISTED
Apigee Corporation Common Stock
APIC
| $3.57M | 0.01% |
429,171
-212,531
| -33% | -$1.58M |
|
709
8x8 Inc
EGHT
$271M
| $3.52M | 0.01% |
+350,153
| New | +$3.84M |
|
710
Emergent Biosolutions
EBS
$377M
| $3.51M | 0.01% |
+96,673
| New | +$3.41M |
|
711
Toll Brothers
TOL
$14.5B
| $3.49M | 0.01% |
118,300
-18,000
| -13% | -$503K |
|
|
KEY.PRG
712
DELISTED
KeyCorp Pfd
KEY.PRG
| $3.47M | 0.01% |
26,595
+4,984
| +23% | +$650K |
|
713
Voya Financial
VOYA
$9.07B
| $3.44M | 0.01% |
115,400
-9,100
| -7% | -$275K |
|
|
LPT
714
DELISTED
Liberty Property Trust
LPT
| $3.43M | 0.01% |
102,600
-44,000
| -30% | -$1.32M |
|
|
TGNA
715
DELISTED
TEGNA Inc
TGNA
| $3.4M | 0.01% |
226,719
-42,344
| -16% | -$643K |
|
|
ACH
716
Accendra Health
ACH
$249M
| $3.4M | 0.01% |
+84,000
| New | +$3.13M |
|
717
Incyte
INCY
$26B
| $3.38M | 0.01% |
46,683
-12,213
| -21% | -$910K |
|
718
Host Hotels & Resorts
HST
$17.4B
| $3.38M | 0.01% |
202,500
-38,500
| -16% | -$579K |
|
719
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.95B
| $3.36M | 0.01% |
+174,916
| New | +$3.13M |
|
|
AA.PRB
720
DELISTED
Alcoa Inc
AA.PRB
| $3.34M | 0.01% |
101,219
+6,216
| +7% | +$182K |
|
|
XLRN
721
DELISTED
Acceleron Pharma
XLRN
| $3.31M | 0.01% |
125,464
-25,776
| -17% | -$750K |
|
|
RKUS
722
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $3.31M | 0.01% |
337,489
-839,167
| -71% | -$7.76M |
|
|
WY.PRA
723
DELISTED
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
| $3.31M | 0.01% |
64,670
-305,167
| -83% | -$14.3M |
|
|
AHL
724
DELISTED
ASPEN Insurance Holding Limited
AHL
| $3.26M | 0.01% |
68,400
-202,450
| -75% | -$9.24M |
|
|
CCF
725
DELISTED
Chase Corporation
CCF
| $3.25M | 0.01% |
61,700
+18,800
| +44% | +$866K |
|
Similar funds
Lord, Abbett & Co's Q1 2016 Portfolio in Review
As of Q1 2016, Lord, Abbett & Co held 1,024 positions worth $31.8B, down 4.4% from $33.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Lord, Abbett & Co withdrew a net $2.38B in Q1 2016, closing 152 positions and reducing 350 holdings. Its most notable exit was American International, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, Lord, Abbett & Co opened a new position in MSC Industrial Direct worth $109M.
- Lord, Abbett & Co's largest Q1 2016 buy was MSC Industrial Direct: 1,432,636 shares worth $109M.
- Lord, Abbett & Co added most to Johnson & Johnson in Q1 2016, an estimated $148M increase.
- Lord, Abbett & Co's biggest Q1 2016 reduction was Merck, cutting an estimated $154M.
- Lord, Abbett & Co fully exited American International in Q1 2016, selling an estimated $149M.
- Lord, Abbett & Co's ten largest holdings make up 10% of its $31.8B portfolio in Q1 2016.
- Lord, Abbett & Co opened 157 new positions and closed 152 in Q1 2016.
- Lord, Abbett & Co's portfolio value fell 4.4% quarter-over-quarter to $31.8B.
Based on Lord, Abbett & Co's 13F filing for Q1 2016, filed 16 May 2016.